Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Medicine. This report contains market size and forecasts of Prostate Cancer Medicine in global, including the following market information:
Global Prostate Cancer Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
LHRH Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Medicine include AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories and Astellas Pharma Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Medicine Market Segment Percentages, by Type, 2022 (%)
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Global Prostate Cancer Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Medicine Market Segment Percentages, by Application, 2022 (%)
Age Below 55
Age 55-75
Age Above 75
Global Prostate Cancer Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Medicine, market overview.
Chapter 2: Global Prostate Cancer Medicine market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Medicine Overall Market Size
2.1 Global Prostate Cancer Medicine Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Medicine Players in Global Market
3.2 Top Global Prostate Cancer Medicine Companies Ranked by Revenue
3.3 Global Prostate Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Medicine Market Size Markets, 2022 & 2029
4.1.2 LHRH Antagonists
4.1.3 LHRH Analogs
4.1.4 Antiandrogens
4.1.5 Pipeline Drugs for Hormonal Therapy
4.2 By Type - Global Prostate Cancer Medicine Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Medicine Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Medicine Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Medicine Market Size, 2022 & 2029
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Medicine Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Medicine Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Medicine Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Medicine Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Medicine Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Medicine Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Medicine Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Medicine Revenue, 2018-2029
6.3.2 US Prostate Cancer Medicine Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Medicine Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Medicine Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Medicine Market Size, 2018-2029
6.4.3 France Prostate Cancer Medicine Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Medicine Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Medicine Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Medicine Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Medicine Revenue, 2018-2029
6.5.2 China Prostate Cancer Medicine Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Medicine Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Medicine Market Size, 2018-2029
6.5.6 India Prostate Cancer Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Medicine Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Medicine Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Medicine Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Medicine Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Medicine Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Medicine Market Size, 2018-2029
7 Prostate Cancer Medicine Companies Profiles
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Summary
7.1.2 AstraZeneca plc Business Overview
7.1.3 AstraZeneca plc Prostate Cancer Medicine Major Product Offerings
7.1.4 AstraZeneca plc Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca plc Key News & Latest Developments
7.2 Active Biotech
7.2.1 Active Biotech Company Summary
7.2.2 Active Biotech Business Overview
7.2.3 Active Biotech Prostate Cancer Medicine Major Product Offerings
7.2.4 Active Biotech Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.2.5 Active Biotech Key News & Latest Developments
7.3 Bristol Myers-Squibb
7.3.1 Bristol Myers-Squibb Company Summary
7.3.2 Bristol Myers-Squibb Business Overview
7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Major Product Offerings
7.3.4 Bristol Myers-Squibb Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers-Squibb Key News & Latest Developments
7.4 Teva Pharmaceuticals Industries Ltd.
7.4.1 Teva Pharmaceuticals Industries Ltd. Company Summary
7.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Major Product Offerings
7.4.4 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Medicine Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Prostate Cancer Medicine Major Product Offerings
7.6.4 Pfizer Inc. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 Bayer AG
7.7.1 Bayer AG Company Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Prostate Cancer Medicine Major Product Offerings
7.7.4 Bayer AG Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.7.5 Bayer AG Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Prostate Cancer Medicine Major Product Offerings
7.8.4 Abbott Laboratories Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Astellas Pharma Inc.
7.9.1 Astellas Pharma Inc. Company Summary
7.9.2 Astellas Pharma Inc. Business Overview
7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Major Product Offerings
7.9.4 Astellas Pharma Inc. Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.9.5 Astellas Pharma Inc. Key News & Latest Developments
7.10 Roche Holding AG
7.10.1 Roche Holding AG Company Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Prostate Cancer Medicine Major Product Offerings
7.10.4 Roche Holding AG Prostate Cancer Medicine Revenue in Global Market (2018-2023)
7.10.5 Roche Holding AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Medicine Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Medicine Market Drivers in Global Market
Table 3. Prostate Cancer Medicine Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Medicine in Global Market
Table 5. Top Prostate Cancer Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Medicine Product Type
Table 9. List of Global Tier 1 Prostate Cancer Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca plc Company Summary
Table 31. AstraZeneca plc Prostate Cancer Medicine Product Offerings
Table 32. AstraZeneca plc Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca plc Key News & Latest Developments
Table 34. Active Biotech Company Summary
Table 35. Active Biotech Prostate Cancer Medicine Product Offerings
Table 36. Active Biotech Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 37. Active Biotech Key News & Latest Developments
Table 38. Bristol Myers-Squibb Company Summary
Table 39. Bristol Myers-Squibb Prostate Cancer Medicine Product Offerings
Table 40. Bristol Myers-Squibb Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers-Squibb Key News & Latest Developments
Table 42. Teva Pharmaceuticals Industries Ltd. Company Summary
Table 43. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product Offerings
Table 44. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Prostate Cancer Medicine Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Inc. Company Summary
Table 51. Pfizer Inc. Prostate Cancer Medicine Product Offerings
Table 52. Pfizer Inc. Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Inc. Key News & Latest Developments
Table 54. Bayer AG Company Summary
Table 55. Bayer AG Prostate Cancer Medicine Product Offerings
Table 56. Bayer AG Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer AG Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories Prostate Cancer Medicine Product Offerings
Table 60. Abbott Laboratories Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Astellas Pharma Inc. Company Summary
Table 63. Astellas Pharma Inc. Prostate Cancer Medicine Product Offerings
Table 64. Astellas Pharma Inc. Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 65. Astellas Pharma Inc. Key News & Latest Developments
Table 66. Roche Holding AG Company Summary
Table 67. Roche Holding AG Prostate Cancer Medicine Product Offerings
Table 68. Roche Holding AG Prostate Cancer Medicine Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Holding AG Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Medicine Segment by Type in 2022
Figure 2. Prostate Cancer Medicine Segment by Application in 2022
Figure 3. Global Prostate Cancer Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca plc Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Active Biotech Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers-Squibb Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Inc. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer AG Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Laboratories Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Astellas Pharma Inc. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Holding AG Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
